HS
MIRM icon

HighVista Strategies’s Mirum Pharmaceuticals MIRM Stock Holding History

HighVista Strategies’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
14,892
-671
-4% -$67.4K 0.4% 71
2026
Q1 		$1.44M Buy
+15,563
New +$1.46M 0.4% 82
2025
Q2 		– Sell
-8,942
Closed -$403K – 165
2025
Q1 		$403K Hold
8,942
– – 0.16% 131
2024
Q4 		$370K Sell
8,942
-4,629
-34% -$193K 0.14% 131
2024
Q3 		$529K Sell
13,571
-6,637
-33% -$265K 0.18% 127
2024
Q2 		$691K Hold
20,208
– – 0.25% 109
2024
Q1 		$508K Buy
+20,208
New +$556K 0.18% 118

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighVista Strategies's MIRM Position: Q2 2026 in Review

HighVista Strategies reduced its Mirum Pharmaceuticals (MIRM) stake by 4.3% in Q2 2026, selling an estimated $67.4K and leaving 14,892 shares worth $1.74M. The position accounts for 0.4% of the portfolio, ranked #71.

HighVista Strategies first reported a position in MIRM in Q1 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • HighVista Strategies held 14,892 shares of Mirum Pharmaceuticals worth $1.74M as of Q2 2026.
  • HighVista Strategies sold 671 Mirum Pharmaceuticals shares in Q2 2026, an estimated $67.4K.
  • Mirum Pharmaceuticals made up 0.4% of HighVista Strategies's portfolio in Q2 2026, its #71 holding.
  • HighVista Strategies first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.